Testing Experimental Medication in Healthy Subjects

A Phase I Study of SB26 in Healthy Volunteers

This study is a Phase I, randomized double-blind, placebo-controlled (within a dose group), single and multiple rising dose study of the intravenous administration of SB26 in healthy volunteers.

Pharmaceutical medication involved
Patients and healthy individuals accepted

Drug - SB26

SB26 administered intravenously

Drug - Placebo

Placebo administered intravenously

A Randomized, Double-blind, Placebo-controlled, Single and Multiple Rising Dose Study to Explore the Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of SB26 in Healthy Volunteers